Cannell & Spears’s Genpact G Stock Holding History

Cannell & Spears’s Portfolio G Stock Details G Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-8,061	Closed	-$292K	–	219
2023 Q3	$292K	Hold	8,061	–	–	0.03%	171
2023 Q2	$303K	Buy	+8,061	New	+$324K	0.02%	182
2021 Q1	–	Sell	-5,236	Closed	-$217K	–	236
2020 Q4	$217K	Sell	5,236 -202	-4%	-$7.98K	0.02%	215
2020 Q3	$212K	Buy	+5,438	New	+$214K	0.02%	213

Other funds holding G

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NIEF

Nalanda India Equity Fund Mauritius $510M AUM 23.61% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Cannell & Spears's G Position: Q4 2023 in Review

Cannell & Spears sold out of Genpact (G) in Q4 2023, closing a stake of 8,061 shares — an estimated $292K sold.

Cannell & Spears first reported a position in G in Q3 2020 and held it in 4 quarters. The position peaked at $303K in Q2 2023. 354 funds tracked by Wall St. Rank hold G as of Q4 2023.

Cannell & Spears reported no remaining Genpact position as of Q4 2023 after selling out during the quarter.
Cannell & Spears sold 8,061 Genpact shares in Q4 2023, an estimated $292K.
Cannell & Spears first reported a position in Genpact in Q3 2020 and held it in 4 quarters.
Cannell & Spears's Genpact position peaked at $303K in Q2 2023.
354 funds tracked by Wall St. Rank held Genpact as of Q4 2023.

Based on Cannell & Spears's 13F filing for Q4 2023, filed 14 Feb 2024.